Blog

by Amy DuRoss | October 13, 2020
Vineti, Inc., the leading digital platform of record for personalized therapeutics, today announced the closing of a $33 million extension to its Series C financing. The new financing will support further expansion of the company’s Personalized…

by Amy DuRoss | October 7, 2020

by Vineti | October 7, 2020
This year’s “Mesa” will be entirely virtual. Vineti completely supports that decision amid the ongoing threat from COVID-19. And yet we also wanted to take a minute to acknowledge what we’ll all miss -- the chance for serendipitous connections and…

by Vineti | August 25, 2020
Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer patients.

by Amy DuRoss | August 17, 2020
Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene therapies.

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required